Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Headache | 23% | x | x | ||
Upper respiratory tract infection | 9% | x | x | ||
Myalgia | 7% | x | x | ||
Sinusitis | 6.53% | 4.04% | x | x | |
Nausea | 5.03% | 1.52% | x | x | |
Pharyngolaryngeal pain | 5.03% | 4.04% | x | x | |
Diarrhoea | 5% | x | x | ||
Hyperbilirubinaemia | postmarketing | x | x | x | |
Jaundice | postmarketing | x | x | x | |
Liver injury | postmarketing | x | x | ||
Sleep disorder | postmarketing | x | x | ||
Arthralgia | x | ||||
Neck pain | x | ||||
Chest pain | x | ||||
Conjunctivitis | x | ||||
Constipation | x | ||||
Dizziness | x | ||||
Dyspepsia | x | x | |||
Rash | x | x | x | ||
Body temperature increased | x | ||||
Flatulence | x | ||||
Gastrointestinal disorder | x | x | |||
Hepatitis | x | ||||
Hypersensitivity | x | x | |||
Hypertonia | x | ||||
Muscle rigidity | x | ||||
Nervousness | x | ||||
Pain | x | ||||
Pruritus | x | ||||
Urinary tract infection | x | ||||
Urticaria | x | ||||
Vaginal inflammation | x | ||||
Vomiting | x | x | x | ||
Malaise | x | ||||
Abdominal pain upper | x | x | |||
Hepatotoxicity | x | x | |||
Chronic liver disease | x | x | |||
Lymphadenopathy | x | ||||
Insomnia | x | ||||
White blood cell count low | x | ||||
Somnolence | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||||
---|---|---|---|---|---|
Asthma | x | x | |||
Liver disorder | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |